Clinical Trials Directory

Trials / Conditions / Relapsed or Refractory B-cell Lymphoma

Relapsed or Refractory B-cell Lymphoma

9 registered clinical trials studyying Relapsed or Refractory B-cell Lymphoma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSelinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
NCT06062641
Ruijin HospitalPhase 2
UnknownJY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
NCT06045585
Guangdong Second Provincial General HospitalEARLY_Phase 1
Not Yet RecruitingA Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphom
NCT05814848
Changhai HospitalPhase 4
RecruitingSecondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
NCT05806580
Ruijin HospitalPhase 4
TerminatedA Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma
NCT05720052
MingSight Pharmaceuticals, IncPhase 1 / Phase 2
UnknownExploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Ly
NCT04887025
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1
UnknownStudy of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma
NCT04056975
EVIVE BiotechnologyPhase 1
UnknownSafety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
NCT03208556
Peking UniversityPhase 1
UnknownCART-19 Cells for R/R B-cell Lymphoma
NCT03391726
Fujian Medical UniversityPhase 2 / Phase 3